DOCSLIB.ORG

M/S. STERMONE CHEMICALS PVT. LTD. BULK-DRUG MANUFACTURING UNIT

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
M/S. STERMONE CHEMICALS PVT. LTD. BULK-DRUG MANUFACTURING UNIT EXECUTIVE SUMMARY of M/s. STERMONE CHEMICALS PVT. LTD. BULK-DRUG MANUFACTURING UNIT Plot No.34/01, Paldi Golana Road, Village: Paldi, Tal: Khambhat, Dist; Anand, Gujarat, EMAIL: [email protected] (Project Area: 14,404 sq.m) PURPOSE: Production Expansion (From 0.405 MT/Month to 10.7475 MT/Month) CATEGORY “B” Prepared By: EXCEL ENVIRO TECH NABET Accredited EIA Consultant Organization Certificate No.: (NABET/EIA/1821/RA 0115) NABL Accredited Laboratory (certificate no. TC-5892) TF-2 , Sun House, Old High Court Lane Off Ashram Road, Ahmedabad – 380 009 Cell: +91-98255 88910.Office No: +91 9687611400 Email: [email protected] www.excelenviro.com Excel Enviro Tech Executive Summary EXECUTIVE SUMMARY A- 1 PROJECT BACKGROUND M/s. Stermone Chemicals Pvt. Ltd. located at Plot No. 34/01, Paldi, Golana Road, Tal: Khambhat, Dist: Anand, Gujarat. The proponent has already existing set-up in the Paldi. The unit is currently manufacturing bulk drug having capacity of 405 Kg/Month. Unit intends expand existing manufacturing capacity and intends to manufacture various life saving bulk drugs as hormones and steroids with a total capacity of 10,747.5 Kg/Month. Looking to the prospective market scenario and considering the large demand of the bulk drug in the market for various purposes and having established set-up, the proponent intends to expand the business at the same project site. The unit is holding Environmental Clearance vide letter no. F. No. J-11011/11/2008-IA II (I), dated 10/09/2009 for exising unit and consent order from GPCB Consolidated Consent & Authorization (CC &A) No. AWH-84821 dated 16/03/2017, valid up to 22/02/2022 the unit is complying with the required statutory conditions. The unit has also obtained the compliance certificate for existing Environmental Clearance dated 26/09/2018. The proposal of expansion by M/s. Stermone Chemicals Pvt. Ltd. falls under category 5(f) of schedule attached to EIA Notification 2006 and needs prior environmental clearance. It is stated that 5(f) industries located outside notified area are classified under category A and would be Ministry of Environment Forest & Climate Change. However, as per further amendment to notification dated 25th June 2014 mentioning that 5(f) industries can be classified under category B project if industry is fulfilling conditions as water consumption less that 25.0 m3/day, fuel consumption not to exceed 25.0 MT/day and storage of hazardous chemicals and fuels within premises not crossing the limits specified in MSIHC rules. The M/s. Stermone Chemicals Pvt. Ltd. Is fulfilling the three conditions and hence classified under Category B project. A-2 MAGNITUDE OF THE PROJECT The existing and proposed production capacity is given in Table-1. Table -1: The Existing And Proposed Production Capacity Sr. Name of Product Existing Proposed Total End Use of No. Capacity Change capacity Product (Kg/Month)* (Kg/Month) (Kg/Month) Existing 1. Beclomethasone Dipropionate 25 0 25 Healthcare 2. Betamethasone Diropionate 50 0 50 3. Betamethasone I.P. 5 0 5 4. Betamethasone Sodium 50 0 50 Phosphate 5. Betamethasone Valerate 50 0 50 6. Clobetasone Propionate 40 0 40 7. Clobetasone Butyrate 10 0 10 8. Dexamethasone and Sodium 50 0 50 Phosphate 9. Fluticasone Propionate 15 0 15 10. Hydrocortisone 20 0 20 11. Hydrocortisone Acetate 20 0 20 12. Mometasone Furoate 20 0 20 ES-1 M/s. Stermone Chemicals Pvt. Ltd. Excel Enviro Tech Executive Summary Sr. Name of Product Existing Proposed Total End Use of No. Capacity Change capacity Product (Kg/Month)* (Kg/Month) (Kg/Month) 13. Prednisolone Acetate 25 0 25 14. Prednisolone Sodium 25 0 25 Phosphate Proposed 1. Testosterone 0 2,260.5 2,260.5 Healthcare 2. Testosterone propionate 0 3. Testosterone Undecanoate 0 4. Testosterone Cypionate 0 5. Nandrolone Decanoate 0 6. Nandrolone Phenylpropionate 0 7. Trenbolone Acetate 0 8. Trenbolone Enanthate 0 9. Methandienone 0 10. Oxymetholone 0 11. Stanozolol 0 12. Tibolone 0 13. Hydroxyprogesterone 0 Caproate 14. Norathisterone Acetate 0 15. Norathisterone Enanthate 0 16. Levonorgestrel 0 17. Desogestrel 0 18. Drospirenone 0 19. Progesterone 0 20. Allylestrenol 0 21. Gestodene 0 22. Lynestrenol 0 23. Exemestane 0 24. Estradiol 0 25. Estrinol 0 26. Estradiol Cypionate 0 27. Ethinyl Estradiol 0 28. Mifepristone 0 29. Oxandrolone 0 30. Medroxy Progesterone 0 Acetate 31. Megestrol Aceate 0 32. Abiraterone acetate 0 33. Betamethasone 0 8,487 8,487 Healthcare 34. Betamethasone Acetate 0 35. Betamethasone Dipropionate 0 36. Betamethasone Valerate 0 37. Betamethasone Sodium 0 Phosphate 38. Clobetasol Propionate 0 39. Clobetasone Butyrate 0 40. Dexamethasone 0 41. Dexamethasone Sodium 0 ES-2 M/s. Stermone Chemicals Pvt. Ltd. Excel Enviro Tech Executive Summary Sr. Name of Product Existing Proposed Total End Use of No. Capacity Change capacity Product (Kg/Month)* (Kg/Month) (Kg/Month) Phosphate 42. Dexamethasone Acetate 0 43. Deflazacort 0 44. Hydrocortisone Acetate 0 45. Prednisolone 0 46. Prednislone Acetate 0 47. Prednisone 0 48. Prednisolone Sodium 0 Phosphate 49. Beclomethasone Dipropionate 0 50. Mometasone Furoate 0 51. Dutasteride 0 52. Halobetasol Propionate 0 53. Fluocinolone Acetonide 0 54. Fluocinonide 0 55. Triamcinolone 0 56. Triamcinolone Acetonide 0 57. Triamcinolone Hexaacetonide 0 58. Difluprednate 0 59. Methylprednislone 0 60. Methylprednisolone Acetate 0 61. Fluticasone Propionate 0 62. Fluromethonolone 0 63. Loteprednol Ethabonate 0 64. Diflucortolone Valerate 0 65. Desoximethasone 0 66. Eplerenone 0 67. Spironolactone 0 68. Hydrocortisone 0 Total 405.0 10,747.5 10,747.5 *The unit would enhance the manufacturing capacity of existing products and the same has been blended in proposed product list. ES-3 M/s. Stermone Chemicals Pvt. Ltd. Excel Enviro Tech Executive Summary A-3 SITE LOCATION The site details indicating the nearest landmarks and amenities are given in Table-2. Table-2: Aerial Distance of Nearest Landmarks Aerial Distance, km Particular Location Name (approx) Khambhat Taluka 5.93 Km SSE Khambhat City Anand District 43.32 Km, NE Anand City Village/Residential Zone Paldi 0.750 Km NNW Railway Station Khambhat Railway Station 6.28 Km SSE Airport Vadodara Airport 65.18 Km E Kheda – Khambhat 2.50 Km E Highway (National & state) SH- 89 5.70 Km SE Gulf of Khambhat 7.10 Km S Nearest major water body Natural Drain 0.6 Km E NECL (Nandesari Environment TSDF 52.0 Km E Control Ltd.) Hospital Cambay General Hospital 5.39 Km SSE Fire Station Sardargunj Fire Station Anand 43.81 Km NE Police Station Khambhat City police station 6.39 Km SSE The proposed expansion would be carried out within existing premises with expansion in existing building and another new building adjacent to the existing one. The existing land area is @14,404 sq.m. The choice of the land / Project confers several advantages, which are summarized below: The unit already exists and have procured applicable permissions for existing plant. Sufficient open space available for expansion within premises. No requirement of new land. The project proponent already possess ready infrastructure for existing capacity; where the product would be manufactured with required modifications. Uninterrupted availability of sufficient water (from GWSSB authority). Availability of Agro waste/Briquette as fuel from nearby source Uninterrupted supply of electricity No physical displacement of the members of the public. Connectivity of the site via road and train to procure the raw material and to despatch the products. A vicinity of habitation to get human resource to run the plant. A- 4 INVESTMENT OF THE PROJECT The total investment for the proposed expansion project would be INR 9.52 crore. The estimated capital cost to be incurred for environmental pollution control measures of the project are around INR 1.22 crore and operational cost to be incurred in future is INR 1.73 Crore / Annum say 14.41 Lacs/Month. ES-4 M/s. Stermone Chemicals Pvt. Ltd. Excel Enviro Tech Executive Summary A- 5 INFRASTRUCTURE & UTILITIES REQUIREMENT A.5.1 AREA REQUIREMENT The units is located in Khambhat, spread over a plot of 14,404 sq. meters, and are easily accessible by road and rail from all over India. Out of total land allotted for plant, approx. 33 % (4754 sq.m.) land will be allocated for green belt development. A.5.2 POWER REQUIREMENT The total power requirement is 1000 KVA and shall be obtained from MGVCL - Madhya Gujarat Vij Company Limited. Existing DG set of 125 KVA and proposed DG set of 500 KVA shall be utilized as stand-by power source after proposed expansion. A.5.3 FUEL REQUIREMENT Agrowaste / Briquette of @300 kg/hourand diesel of @60 Litre / hour shall be used as a fuel in boiler & DG Set respectively. A.5.4 MANPOWER REQUIREMENT Total 88 people shall be employed after proposed expansion. There are 43 existing and 45 proposed employees. A.5.5 WATER REQUIREMENT Water requirement for the project will be met from the GWSSB (Gujarat Water Supply and Sewarage Board) through pipeline. The total water requirement for the project would be 37 KL/day, out of which 23 KL/day will be fresh water and 14 KL/day will be recycled water. A.5.3 EQUIPMENTS & MACHINERIES After proposed expansion chilling tower, cooling tower, reactors, boiler, dryer, stripper, ETP, incinerator and MEE shall be installed. A-6 EMISSIONS, EFFLUENT GENERATION, WASTE GENERATION & SOLVENT RECOVERY A.6.1 ATMOSPHERIC EMISSIONS The existing and proposed flue gas emissions are given in Table-3. Table: 3 - Details of Flue Gas Stack (Existing & Proposed) Sr. Stack attached Height of Fuel APCM Fuel Parameter No. to Stack, m Consumption System Boiler Agro Waste Cyclone 1 (Existing) 1 TPH 13.0 100 kg/Hour / Briquette Separator Particulate Boiler Matter Agro Waste Cyclone 3 2 (proposed) 13.0 200 kg/Hour <150mg/NM / Briquette Separator 2 TPH SO2 < 100 ppm D.G.
Load more

Recommended publications
  • MMC International BV
    M.M.C. International Steroid Substances Steroid Test A Colour Steroid Test B Colour Steroid Test B Colour with UV Light Stanozolol/ Oxandrolone Test Clenbuterol/ Oxymetholone Test Ephedrine Test Alfadolone Orange Yellow Nil - - - Androsterone Orange Yellow White - - - Beclometasone Brown–yellow Orange Nil - - - Betamethasone Orange–brown Pink–Orange Nil - - - Boldenone Base (Equipoise, Ganabol) (pure powder) Warm red after 2 min. Dark Orange after 2 min. Bright Light Orange - - - Boldenone Undecanoate (oil) Dark brownish-red Dark Red Bright Light Orange - - - Boldenone Undecylenate (oil) Orange - Light Brown Dark Orange → Brown Bright Light Orange-Yellow - - - Carbenoxolone (CBX) Orange Yellow Yellow - - - Cholesterol Violet Orange White - - - Clenbuterol (Spiropent, Ventipulmin) - - - - Purple - Dark brown with yellow-green on the Dark brown with yellow-green on the Clomiphene (Androxal, Clomid, Omifin) Nil Dark brown to black No reaction Dark brown to black sides of the ampoule sides of the ampoule Cortisone Orange Yellow Green - - - Desoxycortone Blue–black Yellow Yellow - - - Dexamethasone Yellow Orange–pink Nil - - - Dienestrol Yellow Orange–red Nil - - - Diethylstilbestrol (DES) Orange (→yellow–green) Nil - - - Dimethisterone Brown–green Orange–red Yellow - - - Drostanolone Propionate (Masteron) (oil) Bright green Yellow-Orange Orange - - - Dydrogesterone (Duphaston) - Orange Green-Yellow - - - Enoxolone Orange Yellow Green-Yellow - - - Ephedrine (also for Pseudo- and Nor-Ephedrine) - - - - - Orange Estradiol (Oestradiol) Orange
    [Show full text]
  • Toiminta Unita on Ulla La Mungukurti |
    TOIMINTAUNITA USON 20180071390A1ULLA LA MUNGUKURTI | ( 19) United States (12 ) Patent Application Publication (10 ) Pub. No. : US 2018/ 0071390 A1 PATEL et al. (43 ) Pub . Date : Mar . 15 , 2018 ( 54 ) COMPOSITIONS OF PHARMACEUTICAL A61K 9 / 06 (2006 .01 ) ACTIVES CONTAINING DIETHYLENE A61K 9 /00 (2006 .01 ) GLYCOL MONOETHYL ETHER OR OTHER A61K 31 /573 ( 2006 .01 ) ALKYL DERIVATIVES A61K 31/ 565 ( 2006 .01 ) A61K 31/ 4439 ( 2006 . 01 ) ( 71 ) Applicant : THEMIS MEDICARE LIMITED , A61K 31 / 167 ( 2006 . 01 ) Mumbai (IN ) A61K 31 / 57 (2006 . 01) (52 ) U . S . CI. (72 ) Inventors : Dinesh Shantilal PATEL , Mumbai CPC .. .. .. A61K 47 / 10 ( 2013 . 01 ) ; A61K 9 /4858 ( IN ) ; Sachin Dinesh PATEL , Mumbai ( 2013 .01 ) ; A61K 9 /08 ( 2013 .01 ) ; A61K 9 / 06 ( IN ) ; Shashikant Prabhudas ( 2013 .01 ) ; A61K 9 / 0014 ( 2013 .01 ) ; A61K KURANI, Mumbai ( IN ) ; Madhavlal 31/ 573 ( 2013 .01 ) ; A61K 31 /57 ( 2013 .01 ) ; Govindlal PATEL , Mumbai ( IN ) A61K 31/ 565 ( 2013 .01 ) ; A61K 31 /4439 (73 ) Assignee : THEMIS MEDICARE LIMITED , ( 2013 .01 ) ; A61K 31/ 167 ( 2013 .01 ) ; A61K Mumbai (IN ) 9 /0048 ( 2013 .01 ) ; A61K 9 /0019 (2013 .01 ) ( 57 ) ABSTRACT (21 ) Appl. No .: 15 / 801, 390 The present invention relates to pharmaceutical composi tions of various pharmaceutical actives, especially lyophilic ( 22 ) Filed : Nov . 2 , 2017 and hydrophilic actives containing Diethylene glycol mono ethyl ether or other alkyl derivatives thereof as a primary Related U . S . Application Data vehicle and /or to pharmaceutical compositions utilizing (62 ) Division of application No. 14 /242 , 973 , filed on Apr. Diethylene glycol monoethyl ether or other alkyl derivatives 2 , 2014 , now Pat. No. 9 , 827 ,315 .
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0296.191 A1 PATEL Et Al
    US 20140296.191A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0296.191 A1 PATEL et al. (43) Pub. Date: Oct. 2, 2014 (54) COMPOSITIONS OF PHARMACEUTICAL (52) U.S. Cl. ACTIVES CONTAINING DETHYLENE CPC ............... A61K 47/10 (2013.01); A61 K9/0019 GLYCOL MONOETHYLETHER OR OTHER (2013.01); A61 K9/0048 (2013.01); A61 K ALKYL DERVATIVES 45/06 (2013.01) USPC ........... 514/167: 514/177; 514/178: 514/450; (71) Applicant: THEMIS MEDICARE LIMITED, 514/334: 514/226.5: 514/449; 514/338; Mumbai (IN) 514/256; 514/570; 514/179; 514/174: 514/533; (72) Inventors: Dinesh Shantilal PATEL, Mumbai (IN); 514/629; 514/619 Sachin Dinesh PATEL, Mumbai (IN); Shashikant Prabhudas KURANI, Mumbai (IN); Madhavlal Govindlal (57) ABSTRACT PATEL, Mumbai (IN) (73) Assignee: THEMIS MEDICARE LIMITED, The present invention relates to pharmaceutical compositions Mumbai (IN) of various pharmaceutical actives, especially lyophilic and hydrophilic actives containing Diethylene glycol monoethyl (21) Appl. No.: 14/242,973 ether or other alkyl derivatives thereofas a primary vehicle and/or to pharmaceutical compositions utilizing Diethylene (22) Filed: Apr. 2, 2014 glycol monoethyl ether or other alkyl derivatives thereofas a primary vehicle or as a solvent system in preparation of Such (30) Foreign Application Priority Data pharmaceutical compositions. The pharmaceutical composi Apr. 2, 2013 (IN) ......................... 1287/MUMA2013 tions of the present invention are safe, non-toxic, exhibits enhanced physical stability compared to conventional formu Publication Classification lations containing such pharmaceutical actives and are Suit able for use as injectables for intravenous and intramuscular (51) Int. Cl. administration, as well as for use as a preformed solution/ A647/ (2006.01) liquid for filling in and preparation of capsules, tablets, nasal A6 IK 45/06 (2006.01) sprays, gargles, dermal applications, gels, topicals, liquid oral A6 IK9/00 (2006.01) dosage forms and other dosage forms.
    [Show full text]
  • SEAC) Held on 01/10/2019 at Committee Room, Gujarat Pollution Control Board, Sector 10A,Gandhinagar
    Minutes of the 554 th meeting ofthe State Level Expert Appraisal Committee (SEAC) held on 01/10/2019 at Committee Room, Gujarat Pollution Control Board, Sector 10A,Gandhinagar. The 554 th meeting of the State Level Expert Appraisal Committee (SEAC) was held on 1st October 2019 at Committee Room, Gujarat Pollution Control Board, Sector 10A, Gandhinagar. Following members attended the meeting: 1. Dr. Dinesh Misra, Chairman, SEAC 2. Shri S. C. Srivastav, Vice Chairman, SEAC 3. Shri Rajesh. I. Shah, Member, SEAC 4. Shri V. N. Patel, Member, SEAC 5. Dr. V. K. Jain, Member, SEAC 6. Shri A. K. Mule, Member, SEAC The regular agenda of Appraisal, Screening & Scoping/ToR, Reconsideration cases were taken up. The Committee considered the applications made by project proponents, additional details submitted as required by the SEAC/SEIAA and details furnished in the Form-1, PFR, EIA-EMP reports. Proposal No. Name and Address of the Unit Remarks 04 SIA/GJ/IND2/29059/2017 M/s. Dev Dyechem Industries EC – Plot No. C-1/324, Phase-I & II GIDC – Reconsideration Naroda, Ahmedabad. • PP remained absent in the EC – Appraisal presentation held on 01/10/2019. • After detailed discussion, Committee decided to defer the proposal and consider the same in one of the upcoming meeting of SEAC. 05 SIA/GJ/IND2/29678/2018 M/s. Apex Pharma EC – C-298/2/4, Saykha Industrial Estate, Reconsideration Saykha, Ta- Vagra, Dist -Bharuch. Category of the unit: 5(f) Project status: New • Project proponent (PP) submitted online application vide no. SIA/GJ/IND2/29678/2018 dated 30/04/19 for obtaining Environmental Clearance.
    [Show full text]
  • NEWS 02 2020 ENG.Qxp Layout 1
    Polymers and fluorescence Balance of power 360° drinking water analysis trilogy Fluorescence spectroscopy LCMS-8060NX: performance of industrial base polymers and robustness without Automatic, simultaneous and compromising sensitivity rapid analysis of pesticides and speed CONTENT APPLICATION »Plug und Play« disease screening solution? – The MALDI-8020 in screening for Sickle Cell Disease 4 Customized software solutions for any measurement – Macro programming for Shimadzu UV-Vis and FTIR 8 Ensuring steroid-free food supplements – Identification of steroids in pharmaceuticals and food supplements with LCMS-8045 11 MSn analysis of nonderivatized and Mtpp-derivatized peptides – Two recent studies applying LCMS-IT-TOF instruments 18 Polymers and fluorescence – Part 2: How much fluorescence does a polymer show during quality control? 26 PRODUCTS The balance of power – LCMS-8060NX balances enhanced performance and robustness 7 360° drinking water analysis: Episode 2 – Automatic, simul- taneous and rapid analysis of pesticides in drinking water by online SPE and UHPLC-MS/MS 14 Versatile testing tool for the automotive industry – Enrico Davoli with the PESI-MS system (research-use only [RUO] instrument) New HMV-G3 Series 17 No more headaches! A guide to choosing the perfect C18 column 22 Validated method for monoclonal antibody drugs – Assessment of the nSMOL methodology in Global solution through the validation of bevacizumab in human serum 24 global collaboration LATEST NEWS Global solution through global collaboration – Shimadzu Cancer diagnosis:
    [Show full text]
  • EXECUTIVE SUMMARY Steroids
    EXECUTIVE SUMMARY PREFACE M/s Ratantray Pharmaceuticals Pvt. Ltd. is proposing a project for manufacturing of Vitamins, Steroids & Hormones. SITE DESCRIPTION The said project will come up at H1-174 RIICO, Shree Khatushyam Ji Industrial Area, Reengus, District-Sikar, Rajasthan. The total land available is 500 square metre. The complete land is under acquisition. PROJECTDESCRIPTION M/s Ratantray Pharmaceuticals Pvt. Ltd. is proposing a project for manufacturing of Vitamins, Steroids & Hormones. As per EIA Notification dated 14th Sept., 2006 and amended from time to time, the proposed project falls under Category “B”, Project or Activity 5(f) Synthetic organic chemical Industry. The project is submitted at SEIAA Rajasthan as the proposed project is in notified industrial area. The details of Raw materials are as shown in the table below: Table-1 List of Raw Material S. No. Raw Material Unit Quantity Standard Per Month Per Year (5.0kg batch size) (110kg/month) (Kg) 1 Cyanocobalamin Kg 5.00 100 1200 2 Methyl Iodide Kg 4.50 90 1080 3 Sodium Kg 5.50 110 1320 Borohydride 4 Chloroform Kg 98.00 1960 23520 5 Acetone Kg 60.00 1200 14400 6 Phenol Kg 25.00 500 6000 7 Methanol Kg 13.00 260 3120 The details of Raw materials are as shown in the table below: Table-2 List of Products S. No. Vitamins 1 Methylcobalamin ( Vitamin B12) 2 Hydroxocobalamin Acetate 3 Alfacalcidol (Vitamin D) 4 Ascorbic Acid (Vitamin C) 5 Calcitriol (Vitamin D3) 6 Ergocalciferol (Vitamin D2) 7 Paricalcitol (Vitamin D2) 8 Pyridoxal 5 Phosphate (Vitamin B6) Steroids 1 | Page 1 Beclomethasone
    [Show full text]
  • Injectable Steroids Oral Steroids Post Cycle Therapy Fat Burners Manufacturers Contact Us
    Blog Shopping Cart Wishlist My Account Checkout Search $0.00 Menu STEROIDS SHOP INJECTABLE STEROIDS ORAL STEROIDS POST CYCLE THERAPY FAT BURNERS MANUFACTURERS CONTACT US Injectable Steroids Shop Injectable Steroids SORT BY POPULARITY Search SOLD OUT INJECTABLE STEROIDS Deca Durabolin Equipoise HGH Masteron NPP INJECTABLE STEROIDS Parabolan Androxine $90.00 Primobolan Depot Sustanon 250 Testosterone Cypionate Testosterone Enanthate Testosterone Propionate Testosterone Suspension Trenbolone Acetate Trenbolone Enanthate Trenbolone Suspension Tri Tren Winstrol Depot ORAL STEROIDS INJECTABLE STEROIDS Anadrol Aquaviron Anavar $66.00 Dianabol Halotestin Methyltrienolone Moda됍nil Primobolan Proviron Superdrol Testosterone Undecanoate Turinabol Winstrol POST CYCLE THERAPY Anastrozole EQUIPOISE Boldebolin Cabergoline $60.00 Clomid Exemestane HCG HMG Letrozole Nolvadex FAT BURNERS Clenbuterol Cytomel T3 MANUFACTURERS EQUIPOISE Alpha Pharma Boldebolin (vial) Eminence Labs $55.00 Maxtreme Pharma SOLD OUT EQUIPOISE BoldePrime $69.00 EQUIPOISE Bold-Max $73.00 SOLD OUT EQUIPOISE Bold-One $39.00 SOLD OUT INJECTABLE STEROIDS CypoPrime $43.00 SOLD OUT DECA DURABOLIN DecaPrime $54.00 INJECTABLE STEROIDS Alphabolin $62.00 INJECTABLE STEROIDS Alphabolin (vial) $125.00 SOLD OUT INJECTABLE STEROIDS EnaPrime $43.00 HGH Eutropin 4 IU $55.00 HGH Humatrope $550.00 INJECTABLE STEROIDS Induject-250 $59.00 INJECTABLE STEROIDS Induject-250 (vial) $59.00 SOLD OUT INJECTABLE STEROIDS DrostoPrime $72.00 INJECTABLE STEROIDS
    [Show full text]
  • Influence of Androgens on Circulating Adiponectin in Male and Female Rodents
    Influence of Androgens on Circulating Adiponectin in Male and Female Rodents Joshua F. Yarrow1,2*, Luke A. Beggs1,2, Christine F. Conover1, Sean C. McCoy1, Darren T. Beck3, Stephen E. Borst3,2 1 Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida, United States of America, 2 Department of Applied Physiology & Kinesiology, University of Florida, Gainesville, Florida, United States of America, 3 Malcom Randall Veterans Affairs Medical Center, Geriatrics Research, Education, and Clinical Center (GRECC), Gainesville, Florida, United States of America Abstract Several endocrine factors, including sex-steroid hormones are known to influence adiponectin secretion. Our purpose was to evaluate the influence of testosterone and of the synthetic non-aromatizable/non-5a reducible androgen 17b- hydroxyestra-4,9,11-trien-3-one (trenbolone) on circulating adiponectin and adiponectin protein expression within visceral fat. Young male and female F344 rats underwent sham surgery (SHAM), gonadectomy (GX), or GX plus supraphysiologic testosterone-enanthate (TE) administration. Total circulating adiponectin was 39% higher in intact SHAM females than SHAM males (p,0.05). GX increased total adiponectin by 29–34% in both sexes (p,0.05), while TE reduced adiponectin to concentrations that were 46–53% below respective SHAMs (p#0.001) and ablated the difference in adiponectin between sexes. No differences in high molecular weight (HMW) adiponectin were observed between sexes or treatments. Adiponectin concentrations were highly and negatively associated with serum testosterone (males: r = 20.746 and females: r=20.742, p#0.001); however, no association was present between adiponectin and estradiol. In separate experiments, trenbolone-enanthate (TREN) prevented the GX-induced increase in serum adiponectin (p#0.001) in young animals, with Low-dose TREN restoring adiponectin to the level of SHAMs and higher doses of TREN reducing adiponectin to below SHAM concentrations (p#0.001).
    [Show full text]
  • Customs Tariff - Schedule
    CUSTOMS TARIFF - SCHEDULE 99 - i Chapter 99 SPECIAL CLASSIFICATION PROVISIONS - COMMERCIAL Notes. 1. The provisions of this Chapter are not subject to the rule of specificity in General Interpretative Rule 3 (a). 2. Goods which may be classified under the provisions of Chapter 99, if also eligible for classification under the provisions of Chapter 98, shall be classified in Chapter 98. 3. Goods may be classified under a tariff item in this Chapter and be entitled to the Most-Favoured-Nation Tariff or a preferential tariff rate of customs duty under this Chapter that applies to those goods according to the tariff treatment applicable to their country of origin only after classification under a tariff item in Chapters 1 to 97 has been determined and the conditions of any Chapter 99 provision and any applicable regulations or orders in relation thereto have been met. 4. The words and expressions used in this Chapter have the same meaning as in Chapters 1 to 97. Issued January 1, 2020 99 - 1 CUSTOMS TARIFF - SCHEDULE Tariff Unit of MFN Applicable SS Description of Goods Item Meas. Tariff Preferential Tariffs 9901.00.00 Articles and materials for use in the manufacture or repair of the Free CCCT, LDCT, GPT, following to be employed in commercial fishing or the commercial UST, MXT, CIAT, CT, harvesting of marine plants: CRT, IT, NT, SLT, PT, COLT, JT, PAT, HNT, Artificial bait; KRT, CEUT, UAT, CPTPT: Free Carapace measures; Cordage, fishing lines (including marlines), rope and twine, of a circumference not exceeding 38 mm; Devices for keeping nets open; Fish hooks; Fishing nets and netting; Jiggers; Line floats; Lobster traps; Lures; Marker buoys of any material excluding wood; Net floats; Scallop drag nets; Spat collectors and collector holders; Swivels.
    [Show full text]
  • Trenbolone Acetate”
    STEROIDS ANTI SHOP INJECTABLE ORAL PCT HORMONES ESTROGENS ONLINE GENERIC BLOG Home / Products tagged “Trenbolone acetate” Search products… Trenbolone acetate SEARCH Dosage The rate of administration of the drug varies from 50 to 100 mg per day. However, the latter value is considered overpriced. Acetate in an amount of STEROIDS FOR 50 ml already gives a sufficient level of endurance and an increase in SALE muscle mass. If you do not have daily injections, you can limit yourself to taking 100 ml once every 2 days. In this case, the drug is not completely broken down by the liver. The use of a stimulant in small doses at short intervals makes it possible to increase its bioavailability. Side effects Among the side effects noted: pressure surges, the appearance of aggression and agitation, acne, cases of baldness and increased oily skin were recorded. When taken, the production of the body’s own hormone Alpha Pharma testosterone is suppressed, which leads to a decrease in libido and testicular atrophy. The steroid does not adversely affect the functioning of the Dragon Pharma kidneys, however, the color of the urine may turn red. The effect on the liver is considered moderate. Maxtreme Reception effects Indian Brand Regularly taking injections can achieve: BM Pharmaceuticals • A significant increase in muscle mass (up to 10 kg per course). • Increase the level of IGF by 200%. Healing Pharma • Improving power performance. • Intensive fat burning. Natco Pharma • Decreased cortisol levels. Sun Pharmaceuticals Showing all 6 Sort by popularity
    [Show full text]
  • Annexure I: Legal Undertaking for Three Conditions
    A-1 A-2 A-3 A-4 A-5 A-6 A-7 A-8 A-9 A-10 A-11 A-12 A-13 A-14 A-15 A-16 A-17 A-18 A-19 A-20 A-21 A-22 A-23 A-24 A-25 A-26 NAME OF PRODUCT : TESTOSTERONE MAXIMUM QUANTITY TO BE : 2.2605 MT/Month PRODUCED Raw Materials Require: Raw Materials Quantity in MT/Month (MAXIMUM) 3-Enol ether OR 4-AD 3- 2.9387 ethoxyandrosta-3,5-dien-17-one Ethanol 8.8160 Triethylamine 0.0723 Sodium Borohydride 0.6782 Hydrochloric acid 2.2605 Water 6.7815 Ethyl Acetate 6.7815 MDC 1.1303 Charcoal + Hyflow 0.0452 Brief Process: 3-Enol etherOR 4-AD 3-ethoxyandrosta-3,5-dien-17-one will be converted into 3-Enol hydroxyOR 4-AD 3-ethoxyandrosta-3,5-dien-17-ol in presence of sodium borohydride and triethylamine, further this compound converts into crude testosterone by treating with 10% hydrochloric acid. This crude material purified by charcoal treatment with organic solvents. CHEMICAL REACTIONS: A-27 1. TESTOSTERONE 4- AD -1.3 KG ETHANOL – 3.9 KG WATER 3.0 KG SODIUM BOROHYDRIDE- 0.3KG TRIETHYL AMINE - 0.032 KG HCL (10%) 1.0 KG 9.532 KG CRUDE TESTOSTERON eeTESTOSTERON FILTERATION ML-8.32 kg STRIPPER 1.2 KG 4.5kg Solvent ETHYL ACETATE – 3.0kg (Ethanol)-3.8kg KG MDC – 0.5 KG 4.72 KG CHARCOAL + HYFLOW – 0.02KG ETP / MEE FILTERATION Charcoal +Hyflow-0.02kg Solvent-3.44kg Residue-0.26kg Product – 1.0 kg A-28 NAME OF PRODUCT : TESTOSTERONE PROPIONATE MAXIMUM QUANTITY TO BE : 2.2605 MT/Month PRODUCED Raw Materials Require: Raw Materials Quantity in MT/Month (MAXIMUM) Testosterone 2.2605 MDC 22.605 Pyridine 2.2668 Propionyl chloride 0.9042 Methanol 2.2605 Brief Process: Testosterone propionate reacts with propionyl chloride and yields testosterone propionate in presence of organic solvent MDC and methylene chloride and pyridine which purified by chacoalization process in organic solvent methanol.
    [Show full text]
  • Anabolic Steroids and Peptides Shop in USA
    Anabolic Steroids and Peptides Shop in USA Steroids for Sale Shop Sexual Health Anti Estrogens Skin Weight Loss Hormones & Peptides Hair Loss PCT Gel About us Blog Checkout Cart Home / Products tagged “HCG” HCG Showing all 7 results Default sorting High Quality Gona-Max in USA $60.00 High Quality Fertigyn (Pregnyl) in USA High Quality Fertigyn HP 5000 in USA Read more $31.00 $39.00 Add to cart Add to cart High Quality HCG 10000IU in USA High Quality HCG 2000IU in USA High Quality HCG 5000IU in USA $39.00 $16.00 $24.00 Add to cart Add to cart Add to cart High Quality Ovidac 5000 IU in USA $39.00 Add to cart Search products… SEARCH Filter by price Filter Price: $10 — $60 Product categories Anti Estrogens Gel Hair Loss Hormones & Peptides Injectable Steroids Oral Steroids PCT Sexual Health Skin Uncategorized Weight Loss Product tags Acyclovir (Zovirax) Anastrozole Augmentin Azithromycin Boldenone undecylenate (Equipose) Cabergoline (Cabaser) Clenbuterol hydrochloride (Clen) Clomiphene citrate (Clomid) Drostanolone propionate (Masteron) Exemestane (Aromasin) Fluoxymesterone (Halotestin) Furosemide (Lasix) HCG Human Growth Hormone (HGH) Isotretinoin (Accutane) Letrozole Liothyronine (T3) Mesterolone (Proviron) Methandienone oral (Dianabol) Methenolone acetate (Primobolan) Methenolone enanthate (Primobolan depot) Methyl drostanolone (Superdrol) Methyltrienolone (Methyl trenbolone) Moda됍nil Nandrolone decanoate (Deca) Nandrolone phenylpropionate (NPP) Oxandrolone (Anavar) Oxymetholone (Anadrol) Sildena됍l Citrate Stanozolol injection (Winstrol depot) Stanozolol oral (Winstrol) Sustanon 250 (Testosterone mix) Tadala됍l Tamoxifen citrate (Nolvadex) Testosterone cypionate Testosterone enanthate Testosterone propionate Testosterone suspension Testosterone undecanoate Trenbolone acetate Trenbolone enanthate Trenbolone Enanthate, Testosterone Enanthate, Drostanolone Enanthate Trenbolone hexahydrobenzylcarbonate Trenbolone Mix (Tri Tren) Turinabol (4-Chlorodehydromethyltestosterone) Dentist WordPress Theme By VWThemes.
    [Show full text]